Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02820961
Title Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Syndax Pharmaceuticals

estrogen-receptor positive breast cancer


Entinostat + Exemestane

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.